![1064286SPK_250x200[1] chris wagner emerald health therapeutics](https://www.wallstreetreporter.com/wp-content/uploads/2018/03/1064286SPK_250x2001.jpg)
Emerald Health Therapeutics Inc. (TSX.V: EMH) CEO Chris Wagner on Medical Marijuana Trends
![1064286SPK_250x200[1] chris wagner emerald health therapeutics](https://www.wallstreetreporter.com/wp-content/uploads/2018/03/1064286SPK_250x2001.jpg)
TORONTO, Nov. 13, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or the “Company“) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that the license of its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”) under the […]
Medicine Man Technologies Adds Marijuana Research Company, Branded Product Lines and Intellectual Property Development Capabilities to Their International Base of Over 100 Clients DENVER, CO/ January 15, 2019 / Medicine Man Technologies (OTCQX: MDCL), a leading […]
DENVER, Dec. 11, 2018 — US-based Elixinol (OTC: ELLXF) announces the distribution of its first globally available, all-natural, hemp-based skin care and hair care line, Sativa. Get our FREE Newsletter! Discover Stocks with +1,000% Upside […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.